KDR p.Cys482Arg
c.1444T>C · rs34231037 · VCV12318
Computational evidence
| Protein change | ||
| AlphaMissense | 0.751 | likely pathogenic |
|---|---|---|
| REVEL | 0.74 | pathogenic-leaning |
| SaProt | LLR -9.19 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 2.6, phastCons 1 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 23 kb · p 0.092 · regional, not allelic |
| Overall | ||
| CADD | 23.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 11.4% | 9 |
| Finnishnot grpmax-eligible | 4.21% | 24 |
| Middle Easterngrpmax | 3.58% | 28 |
| European (non-Finnish) | 3.19% | 31 |
| Remaining individualsnot grpmax-eligible | 2.58% | 39 |
| Ashkenazi Jewishnot grpmax-eligible | 1.8% | 55 |
| Admixed American | 1.37% | 73 |
| South Asian | 0.741% | 135 |
| African / African-American | 0.544% | 184 |
| East Asian | 0.00223% | 44,768 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- KDR
- Protein
- p.Cys482Arg
- Coding
- c.1444T>C
- MANE Select
- NM_002253
- dbSNP
- rs34231037
- Type
- single nucleotide variant
- Location
- chr4:55106779 (GRCh38)
- Gene constraint
- LOEUF 0.328 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 71.67 · 54 PDB
- Residue 482
- a β-strand; a disulfide bond; a UniProt-annotated variant site (probable risk factor for hci; expression of flt1 in hemangioma endothelial cells is markedly reduced and kdr activity is increased compared to controls; low flt1 expression in hemangioma cells is caused by reduced activity of a pathway involving itgb1, antxr1, kdr and nfatc2ip; the mutation predicts to result in loss-of-function and disruption of the normal association of these molecules); the ig-like c2-type 5 domain
Similar variants
- KDR p.Ala379Val Uncertain significance ★★ ⚠ same condition
- KDR p.Ala757Gly Uncertain significance ★★ ⚠ same condition
- KDR p.Asp832His Uncertain significance ★★ ⚠ same condition
- KDR p.Val416Ala Uncertain significance ★★ ⚠ same condition
- KDR p.Glu372Asp Benign ★★ ⚠ same condition
- KDR p.Thr771Met Likely benign ★★ same condition
- KDR p.Ala1065Thr Uncertain significance ★ ⚠ same condition
- KDR p.Arg946His Uncertain significance ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kdr-p-cys482arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown